TE

Thomas Ebeling

North America, Massachusetts, United States, Boston

Description

Thomas Ebeling a standing member of OIF’s MSAB. After earning a degree in psychology in Hamburg, Thomas, began his career with Reemtsma in 1...

Investor Profile

Thomas Ebeling has made 2 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (50%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Data Center Automation
  • Database
  • Information Technology
  • Biotechnology
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Thomas Ebeling frequently co-invest with?

Infinita Fund
North America, Islas de la Bahia, Honduras, Roatán
Co-Investments: 1
Basis Set Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Emerging Longevity Ventures
North America, Florida, United States, West Palm Beach
Co-Investments: 1
MV
North America, California, United States, San Francisco
Co-Investments: 1
VitaDAO
North America, Ontario, Canada, Ottawa
Co-Investments: 1
Healthspan Capital
North America, California, United States, El Cerrito
Co-Investments: 1
1517 Fund
North America, California, United States, Oakland
Co-Investments: 1
Illusian Family Office
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 1
Fifty Years
North America, California, United States, San Francisco
Co-Investments: 1
JC
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does Thomas Ebeling often collaborate with?

Balaji Srinivasan
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
JD
North America, California, United States, Palo Alto
Shared Deals: 1
KP
North America, California, United States, San Francisco
Shared Deals: 1
Shared Deals: 1
AF
North America, California, United States, San Francisco
Shared Deals: 1
Shared Deals: 1
TP
North America, California, United States, San Francisco
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Thomas Ebeling?

ImmuneAGE Bio is a drug discovery platform focused on rejuvenating the immune system.

BiotechnologyHealth Care
SeedJul 12, 2024
Amount Raised: $2,000,000
Elicit

Oakland, California, United States

Elicit uses language models to help users automate research workflows.

Artificial Intelligence (AI)Data Center AutomationDatabaseInformation Technology
SeedSep 25, 2023
Amount Raised: $9,000,000